(Q39183948)

9 September 2017

title

Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study (English)

1 reference

acute decompensated heart failure

9 September 2017

0 references

1 reference

8

Gerasimos Filippatos

1 reference

9 September 2017

15

Marco Metra

1 reference

9 September 2017

6

Piotr Ponikowski

1 reference

9 September 2017

1

G Michael Felker

1 reference

9 September 2017

3

John R Teerlink

1 reference

9 September 2017

4

Adriaan A Voors

1 reference

9 September 2017

2

Robert J Mentz

1 reference

9 September 2017

9

Beth A Davison

1 reference

9 September 2017

7

Barry H Greenberg

1 reference

9 September 2017

5

Peter S Pang

1 reference

9 September 2017

12

Tsushung A Hua

1 reference

9 September 2017

10

Gad Cotter

1 reference

9 September 2017

Margaret F Prescott

11

1 reference

9 September 2017

Sara Lopez-Pintado

series ordinal

13

1 reference

9 September 2017

Thomas Severin

series ordinal

14

1 reference

9 September 2017

publication date

3 September 2015

1 reference

European Journal of Heart Failure

9 September 2017

published in

1 reference

9 September 2017

volume

17

1 reference

9 September 2017

issue

12

1 reference

9 September 2017

page(s)

1262-1270

1 reference

Troponin elevation in heart failure prevalence, mechanisms, and clinical implications

9 September 2017

cites work

1 reference

Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study

21 January 2018

1 reference

Cardiac troponin and outcome in acute heart failure

21 January 2018

1 reference

Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study

21 January 2018

1 reference

Design of the RELAXin in acute heart failure study.

21 January 2018

1 reference

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial

21 January 2018

1 reference

Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes

21 January 2018

1 reference

Effect of serelaxin on mode of death in acute heart failure: results from the RELAX-AHF study

21 January 2018

1 reference

The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T.

21 January 2018

1 reference

Serial measure of cardiac troponin T levels for prediction of clinical events in decompensated heart failure.

21 January 2018

1 reference

Relation between cardiac troponin I and mortality in acute decompensated heart failure

21 January 2018

1 reference

Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward

21 January 2018

1 reference

Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/EJHF.341

1 reference

release_oadbiq4hynd7hg3zrh3x2jylum

9 September 2017

Fatcat ID

0 references

1 reference